Many drugs and medical devices are currently taking heat for unexpected side effects and complications, but one manufacturer is at the forefront of the conversation: Johnson & Johnson.
Risperdal Manufacturers Docked Again For Failure-to-Warn
A trial in the Philadelphia Court of Common Pleas reached another verdict on a case concerning Johnson & Johnson’s drug Risperdal on Friday, March 20, ruling that while the company failed to adequately warn about a major side effect, it would not award damages to plaintiff William Cirba.
Johnson & Johnson to Pay $2.5 Million in Risperdal Damages
Johnson and Johnson has to pay $2.5 million in damages to the family of a boy who developed size 46 DD breasts from taking the drug Risperdal.
Johnson & Johnson to Pay $136 Million Risperidone Penalty
On Feb. 26, 2015, South Carolina’s Supreme Court ordered Johnson & Johnson to pay $136 million is Risperdal lawsuit penalties.
Risperdal Gynecomastia Lawsuits Are Back on the Rise
Risperdal, an antipsychotic developed by the Janssen brand of Johnson & Johnson, has long been approved by the Food and Drug Administration for schizophrenia.